Neuralink has implanted brain chip in its first human patient, claims Elon Musk

Neuralink, the brain-machine interface startup founded by Elon Musk, has successfully implanted a brain chip in its first human patient, according to a recent announcement by Musk on the social media platform X. Musk reported that the patient is recovering well, and the initial outcomes of the procedure show promise.

The innovative brain implant developed by Neuralink is designed to empower individuals with traumatic injuries to operate computers through their thoughts.

In May last year the company secured approval from the US Food and Drug Administration (FDA) to commence its initial human trials, targeting individuals with quadriplegia resulting from cervical spinal cord injury or amyotrophic lateral sclerosis (ALS).

Elon Musk revealed that Neuralink’s inaugural product, named “Telepathy,” aims to facilitate control over phones, computers, and a wide range of devices simply by thinking.

The initial users of this technology are envisioned to be individuals who have lost the use of their limbs, with Musk emphasizing the potential for enhanced communication capabilities, citing the example of the late physicist Stephen Hawking.

In his X post, Musk highlighted positive results in neuron spike detection, indicating successful recordings from the patient’s brain.

Experts have noted the significance of Neuralink’s achievement but emphasized the need for the company to demonstrate superiority over other leading players in the field, such as Blackrock Neurotech and Synchron.

Neuralink has previously conducted extensive experiments on animals, including monkeys playing computer games using brain signals. However, this has raised concerns among animal rights groups like the Physicians Committee for Responsible Medicine.

Elon Musk’s announcement follows years of anticipation, with Musk predicting human implantation as early as July 2019. While other companies, including Synchron, have made strides in human brain implants, Neuralink’s recent success is expected to mitigate criticism about potential delays.

Despite this progress, a commercial brain implant from Neuralink is not imminent. Jaimie Henderson, a neurosurgery professor at Stanford University and adviser to Neuralink, cautioned against overhyping the technology, stating that an approved device is still years away.

The challenging task ahead involves demonstrating the safety and efficacy of Neuralink’s chips, which penetrate less than 2mm into the brain, in subsequent studies following the initial human trials. The company aims to perform 11 surgeries in 2024, marking a pivotal year for the development of this groundbreaking technology.

(With inputs from agencies)



from Firstpost Tech Latest News https://ift.tt/83bPCZj

Comments

Post a Comment

Popular posts from this blog

COVID-19 origins: Should we pay more attention to the lab leak theory and formally investigate it?

Image
A year and a half into the pandemic, we still do not know exactly where the SARS-CoV-2 virus, which causes Covid-19, came from. The prevailing view so far has been that the virus “spilled over” from bats into humans. But there are increasing calls to investigate the possibility that it emerged from a lab in Wuhan, China, where Covid first appeared at the end of 2019. So what do we know for sure, and what do we need still to find out? We know the sequence of the SARS-CoV-2 virus is close to that of bat coronaviruses . Several decades ago its “ancestor” was circulating in bat populations in southern Asia. But there are still many unanswered questions: we don’t know how the virus arrived in Wuhan, how its sequence evolved to allow human infection, and under what conditions it infected the first people who crossed its path. And for each of these stages, we don’t know whether there was a human contribution (direct or indirect). Zoonotic transmission pathways, in other words the pas
Read more

Menstrual cups are cheaper, more sustainable than pads and tampons for women

Image
Every year in America, women spend at least US$2.8 billion on sanitary pads and tampons that can take hundreds of years to decompose . Is there a more economical and environmentally friendly way? To find out, we asked Susan Powers , a professor of sustainable environmental systems at Clarkson University about her work comparing the environmental impact of tampons, sanitary pads and menstrual cups. What is a menstrual cup? A menstrual cup is a type of reusable feminine hygiene product. It’s a small, flexible bell-shaped cup made of rubber or silicone that a woman inserts into her vagina to catch and collect menstrual fluid. It can be used for up to 12 hours, after which it is removed to dispose of the fluid and cleaned. The cup is rinsed with hot water and soap between each insertion and sterilized in boiling water at least once per period. A cup can last up to 10 years . Although menstrual cups have been around for decades, they historically have been less popular than pads or ta
Read more

Human bodies respond to infections differently depending on the time of day

Image
When microorganisms – such as bacteria or viruses – infect us, our immune system jumps into action. It’s highly trained to sense and eliminate infections and clear up any damage caused by them. It’s typically assumed our immune systems work the exact same way regardless of whether an infection occurs during the day or at night. But research spanning over half a century now shows our bodies actually respond differently at day and night. The reason for this is our body clock, and the fact that each cell in the body, including our immune cells, can tell what time of day it is. Our body clock has evolved over millions of years to help us survive. Every cell in the body has a collection of proteins that indicate the time depending on their levels. Knowing whether it’s day or night means our body can adjust its functions and behaviours (such as when we want to eat) to the correct time. Our body clock does this by generating 24 hour rhythms (also termed circadian rhythms ) in how cells f
Read more